Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited)

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]        
Grant Revenues $ 24 $ 78
Operating Expenses:        
Research and Development 2,093 2,177 7,803 5,751
General and Administrative (199) 1,437 3,630 3,902
Total operating expenses 1,894 3,614 11,433 9,653
Loss from operations (1,894) (3,590) (11,433) (9,575)
Other income (expense)        
Interest income 51 45 141 134
Realized gain (loss) on marketable securities (1,686)
Other income (expense), net 1 (1)
Change in fair value of warrants for the year ended December 31, 2014 (38) 3,036 2,173 (8,494)
Total other income (expense), net 13 3,082 2,313 (10,046)
Loss before income taxes (1,881) (508) (9,120) (19,621)
Income Tax Expense (52)
Net income (loss) $ (1,881) $ (508) $ (9,120) $ (19,673)
Net loss per common share:        
Income (loss) per share, basic $ 0.00 $ 0.00 $ (.01) $ (0.03)
Weighted average common shares outstanding, basic 707,478 694,375 702,634 609,803
Income (loss) per share, fully diluted $ 0.00 $ (0.01) $ (.02) $ (0.03)
Weighted average common shares outstanding, diluted 707,478 696,946 703,417 609,803